Regents of the University of California »

Intellia Therapeutics shares owned by Regents of the University of California

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Regents of the University of California from 13F filings

Historical chart of Regents of the University of California investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Regents of the University of California consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Regents of the University of California

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.6M 117k 30.49
2023-09-30 $3.5M 111k 31.62
2023-06-30 $4.5M 111k 40.78
2023-03-31 $4.2M 111k 37.27
2022-12-31 $3.9M 111k 34.89
2022-09-30 $6.2M 111k 55.96
2022-06-30 $5.8M 111k 51.76
2022-03-31 $8.1M 111k 72.67
2021-12-31 $13M 111k 118.24
2021-09-30 $15M 111k 134.15
2021-06-30 $18M 111k 161.91
2021-03-31 $8.9M 111k 80.26
2020-12-31 $6.1M 111k 54.40
2020-09-30 $2.2M 111k 19.88
2020-06-30 $2.3M 111k 21.02
2020-03-31 $1.4M 111k 12.23
2019-12-31 $1.6M 111k 14.67
2019-09-30 $1.5M 111k 13.35
2019-06-30 $1.8M 111k 16.37
2019-03-31 $11M 524k 21.09
2018-12-31 $7.2M 524k 13.65
2018-09-30 $15M 524k 28.62
2018-06-30 $14M 524k 27.36
2018-03-31 $11M 524k 21.09
2017-12-31 $10M 524k 19.22